DOES CHOLECALCIFEROL CORRECT SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS?

被引:0
|
作者
Capusa, Cristina [1 ,2 ]
Stancu, Simona [1 ,2 ]
Torsin, Ligia [1 ]
Chiriac, Corina [1 ]
Viasu, Liliana [2 ]
Maria, Daniela [3 ]
Mota, Eugen [3 ]
Mircescu, Gabriel [1 ,2 ]
机构
[1] Carol Davila Univ Med & Pharm, Nephrol, Bucharest, Romania
[2] Dr Carol Davila Teaching Hosp Nephrol, Nephrol, Bucharest, Romania
[3] Emergency Cty Hosp, Nephrol, Craiova, Romania
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
MP382
引用
收藏
页码:1467 / 1467
页数:1
相关论文
共 50 条
  • [1] Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease
    Abbas, Fizza
    Coyne, Daniel W.
    [J]. KIDNEY RESEARCH AND CLINICAL PRACTICE, 2019, 38 (02) : 141 - 144
  • [2] A COST-EFFECTIVENESS MODEL FOR SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE
    Lilja, M.
    Lauppe, R.
    Intorcia, M.
    Dubois, E. M.
    Csomor, P.
    Strom, O.
    [J]. VALUE IN HEALTH, 2019, 22 : S913 - S914
  • [3] Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
    Perez-Ricart, Ariadna
    Galicia-Basart, Maria
    Comas-Sugranes, Dolors
    Cruzado-Garrit, Josep-Maria
    Segarra-Medrano, Alfons
    Montoro-Ronsano, Jose-Bruno
    [J]. KIDNEY RESEARCH AND CLINICAL PRACTICE, 2019, 38 (02) : 229 - 238
  • [4] TREATMENT EFFECTS IN SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE: A SYSTEMATIC LITERATURE REVIEW
    Gunnarsson, J.
    Lauppe, R.
    Widen, J.
    Intorcia, M.
    Dubois, E. M.
    Csomor, P.
    [J]. VALUE IN HEALTH, 2019, 22 : S913 - S913
  • [5] Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease
    Markus Ketteler
    Patrice Ambühl
    [J]. Journal of Nephrology, 2021, 34 : 1405 - 1418
  • [6] META-ANALYSIS OF NUTRITIONAL VITAMIN D FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE
    Gunnarsson, Joel
    Lauppe, Rosa
    Kaiser, Edelgard
    Soro, Marco
    Csomor, Philipp
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1214 - 1214
  • [7] Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease
    Ketteler, Markus
    Ambuhl, Patrice
    [J]. JOURNAL OF NEPHROLOGY, 2021, 34 (05) : 1405 - 1418
  • [8] ERGOCALCIFEROL VERSUS CHOLECALCIFEROL IN NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: A RETROSPECTIVE COHORT STUDY
    Yun, Sang-A
    Al-Makki, Akram
    Overholser, Brian
    Shepler, Brian
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 599 - 599
  • [9] DOES ALLOPURINOL IMPROVE CARDIOVASCULAR AND KIDNEY RISK IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS?
    Mehedinti, Ana-Maria
    Popa, Otilia
    Lipan, Mariana
    Dumitru, Dana
    Mircescu, Gabriel
    Capusa, Cristina
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1445 - 1445
  • [10] Ergocalciferol Versus Cholecalciferol in Non-Dialysis Dependent Chronic Kidney Disease Patients: A Small Retrospective Cohort Study
    Al-Makki, Akram
    Frost, Kaitlin
    Yun, Sang-A
    Overholser, Brian
    Shepler, Brian
    [J]. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2019, 22 : 593 - 598